Update on Anal Cancer Prevention, Screening, Treatment and Observation in HIV Medicine
Stephen E. Goldstone, MD, FACS
Assistant Clinical Professor of Surgery
Icahn School of Medicine at Mount Sinai, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Stephen E. Goldstone is an Assistant Clinical Professor of Surgery at The Icahn School of Medicine at Mount Sinai and has a surgical practice in New York City. Dr. Goldstone has spoken at conferences around the world and has done extensive research on human papillomavirus (HPV). His work has been published in many prestigious medical journals and is currently involved in testing both prevention and treatment procedures for HPV. He is a past-president of the International Anal Neoplasia Society and a member of the AIDS Malignancy Consortium.
At the completion of this educational session, learners will:
- Be aware of the progression rates of AIN3 to invasive anal cancer.
- Know who is at risk for progression.
- Understand the problems of close follow-up for patients with AIN3.
- Appreciate the possible utility of HPV testing as a tool when screening for anal dysplasia.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
